peroxynitrous acid has been researched along with lipoxin a4 in 1 studies
Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (lipoxin a4) | Trials (lipoxin a4) | Recent Studies (post-2010) (lipoxin a4) |
---|---|---|---|---|---|
3,303 | 21 | 1,230 | 833 | 17 | 398 |
Protein | Taxonomy | peroxynitrous acid (IC50) | lipoxin a4 (IC50) |
---|---|---|---|
Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.0001 | |
N-formyl peptide receptor 2 | Homo sapiens (human) | 0.0119 | |
Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.0001 | |
Transcription factor p65 | Homo sapiens (human) | 0.0001 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Filep, JG; József, L; Petasis, NA; Serhan, CN; Zouki, C | 1 |
1 other study(ies) available for peroxynitrous acid and lipoxin a4
Article | Year |
---|---|
Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Cell Nucleus; Cell Survival; Dose-Response Relationship, Drug; Humans; Hydroxyeicosatetraenoic Acids; Interleukin-8; Leukocytes; Lipoxins; Lymphocytes; Neutrophils; NF-kappa B; Peroxynitrous Acid; Ribonucleases; Superoxides; Transcription Factor AP-1 | 2002 |